Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 78,635 | 130,695 | 93,765 | 107,526 | 122,430 |
| Marketable Securities | 600,594 | 642,553 | 319,968 | 371,158 | 433,727 |
| Receivables | 46,976 | 32,832 | 20,156 | 16,934 | 15,188 |
| Inventories | 25,022 | 7,893 | 7,948 | 8,167 | 7,769 |
| TOTAL | $789,206 | $848,342 | $467,281 | $533,243 | $601,303 |
| Non-Current Assets | |||||
| PPE Net | 2,137 | 2,185 | 1,791 | 1,936 | 1,761 |
| Other Non-Current Assets | 20,563 | 18,053 | 20,850 | 21,797 | 22,632 |
| TOTAL | $22,700 | $20,238 | $22,641 | $23,733 | $24,393 |
| Total Assets | $811,906 | $868,580 | $489,922 | $556,976 | $625,697 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,749 | 11,649 | 8,691 | 12,031 | 15,941 |
| Accrued Expenses | 35,659 | 28,901 | 31,970 | 31,783 | 28,886 |
| TOTAL | $70,634 | $59,074 | $53,357 | $49,896 | $50,422 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 19,075 | 16,756 | 18,675 | 20,324 | 21,689 |
| TOTAL | $19,075 | $16,756 | $18,675 | $20,324 | $21,689 |
| Total Liabilities | $89,709 | $75,830 | $72,032 | $70,220 | $72,111 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 94,402 | 94,324 | 93,594 | 81,463 | 81,342 |
| Common Shares | 9 | 9 | 8 | 8 | 8 |
| Retained earnings | -1,379,952 | -1,293,349 | -1,221,230 | -1,135,496 | -1,058,588 |
| Other shareholders' equity | -4,802 | -3,328 | -364 | 94 | 177 |
| TOTAL | $722,197 | $792,750 | $417,890 | $486,756 | $553,586 |
| Total Liabilities And Equity | $811,906 | $868,580 | $489,922 | $556,976 | $625,697 |